← Back to Analyst Consensus 
LTRN Buy
Lantern Pharma Inc.
Current Price —
Implied Upside —
Analysts 8
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Next Earnings
Nov 11, 2026 (15 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Apr 2, 2025 | Lake Street | initiate | — → Buy | $25 | 47% |
| Apr 25, 2024 | HC Wainwright & Co. | reiterate | — → Neutral | $0 | 44% |
| Aug 10, 2023 | EF Hutton | reiterate | Buy → Buy | $11 | 30% |
| Jun 26, 2023 | EF Hutton | maintain | Buy → Buy | $11 | 30% |
| May 18, 2023 | HC Wainwright & Co. | initiate | — → Neutral | $0 | 44% |
| Mar 21, 2023 | EF Hutton | reiterate | — → Buy | $11 | 30% |
| Feb 15, 2023 | EF Hutton | maintain | — → Buy | $11 | 30% |
| Nov 1, 2022 | EF Hutton | initiate | — → Buy | $11 | 30% |
| Mar 11, 2022 | HC Wainwright & Co. | maintain | — → Buy | $36 | 44% |
| Nov 2, 2021 | HC Wainwright & Co. | maintain | — → Buy | $34 | 44% |
| Oct 7, 2021 | HC Wainwright & Co. | initiate | — → Buy | $32 | 44% |
| Jul 28, 2020 | Colliers Securities | initiate | — → Buy | $24 | — |
Price Target Trend
Mar 30, 2026 Oct 27, 2026
EPS Estimates
0q —
+1q —
+1y —
0y —
Cross-Platform Signals
No cross-platform signals in the last 90 days